Clinical Trial Update: A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing the efficacy and tolerability of Faslodex versus Arimidex in metastatic breast cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Faslodex (fulvestrant)

Snippet

Sponsor: AstraZeneca | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2009-08-12